Treatments for Improving Mood in Depressed Teens-2
TeenThrive
Adaptation and Pilot Study of Yoga to Reduce Depression in Adolescents
2 other identifiers
interventional
11
1 country
1
Brief Summary
Phase 2: Open Trial N=12 adolescents will be enrolled into a single-arm pilot trial to test the adapted hatha yoga intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Mar 2019
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2019
CompletedResults Posted
Study results publicly available
March 23, 2022
CompletedMarch 23, 2022
February 1, 2022
6 months
January 30, 2019
October 26, 2021
February 28, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Acceptability
Acceptability assessed based on number of participants who remained in the intervention (retention).
Post intervention (month 3)
Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale
Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are scored on a range of 0-1. Higher scores indicate greater credibility.
Week 1
Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale
Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 with higher scores indicating greater expectations.
Week 1
The Client Satisfaction Questionnaire (CSQ-8)
Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.
Post intervention (month 3)
Home Practice Questionnaire
Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.
Post intervention (month 3)
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)
Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.
Post intervention (month 3)
Secondary Outcomes (1)
Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)
post intervention (month 3)
Study Arms (1)
Hatha Yoga
EXPERIMENTAL12 weeks of modified Hatha Yoga specifically designed to be administered to teens with depression.
Interventions
Eligibility Criteria
You may qualify if:
- Adolescents must have elevated depressive symptoms, defined by a score of 11 or higher on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS.
- Other treatment for depression must be stable at baseline. Adolescents do not have to be in other treatment for depression, but, if they are, it must be stable for the past 12 weeks.
- Adolescents must be aged 13-18.
- Adolescents must be medically cleared for moderate physical activity by their primary care physician. This criterion may be met by a current (dated in the past year) statement from their pediatrician that the adolescent may participate in school or camp programs including physical education.
- Adolescents must be able to read and write English sufficient to complete informed consent and engage in interventions.
- Adolescents aged 13-17 must assent to be in the study, and their parent or legal guardian must consent to their participation. Adolescents aged 18 must consent to be in the study.
- Able to attend one of the class times.
You may not qualify if:
- QIDS- A-CR may not be higher than a score of 21. This ensures that adolescents are not severely depressed.
- Adolescents who meet criteria for:
- Current (past year) autism spectrum disorder (AS), if of sufficient severity to interfere with study treatment per clinician judgment;
- Schizophrenia;
- Bipolar disorder;
- Clinically significant psychotic symptoms in the past month;
- Anorexia or Bulimia in past 3 months
- Substance use disorders in the past 12 months and symptoms are of sufficient severity to interfere with study treatment per clinician judgment These will be assessed with the Mini-International Neuropsychiatric Interview (MINI).
- Adolescents may not have current suicide ideation or behavior that warrants immediate treatment. They may have passive ideation (i.e., thoughts that life is not worth living), but may not have active suicide ideation, intent, plan, or an attempt within the previous 6 months.
- Adolescents cannot currently be engaged in or yoga classes, as this is the study intervention.
- Adolescents cannot be pregnant as yoga should be modified for pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- Butler Hospitalcollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Lisa Uebelacker
- Organization
- Butler Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Uebelacker, PhD
Butler Hospital
- PRINCIPAL INVESTIGATOR
Shirley Yen, PhD
Brown University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2019
First Posted
February 5, 2019
Study Start
March 1, 2019
Primary Completion
August 14, 2019
Study Completion
August 29, 2019
Last Updated
March 23, 2022
Results First Posted
March 23, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- One year after study collection.
- Access Criteria
- Information available upon request, please send to PIs Lisa Uebelacker or Shirley Yen.
All IPD underlying publication if required by journal.